Furuya S, Irie F, Hashikawa T, Nakazawa K, Kozakai A, Hasegawa A, Sudo K, Hirabayashi Y
Laboratory for Glyco-Cell Biology, Institute of Physical and Chemical Research (RIKEN), Saitama, Japan.
J Biol Chem. 1994 Dec 23;269(51):32418-25.
The alpha-series ganglioside, IV3NeuAc,III6NeuAcGgOse4-Cer(GD1 alpha), was previously identified as a minor constituent in bovine brain gangliosides (Hirabayashi, Y., Hyogo, A., Nakao, T., Tsuchiya, K., Suzuki, Y., Matsumoto, M., Kon, K, and Ando, S. (1990) J. Biol. Chem. 265, 8144-8151). In the present study, we have generated a specific mouse monoclonal antibody against GD1 alpha and explored the distribution of GD1 alpha in murine central nervous system. In adult rat brain, GD1 alpha occurred as a minor constituent, and its expression was exclusively detected in the forebrain, the midbrain and the cerebellum. In the mouse cerebellum, the content of GD1 alpha was reduced significantly in the Purkinje cell-deficient mutants, lurcher (Lc/+), staggerer (sg/sg), and Purkinje cell degeneration (pcd/pcd), but were not reduced in the weaver (wv/wv) mutant, which loses mostly granule cells. The GD1 alpha synthase, assayed in cerebellar microsomes, was also reduced in Purkinje cell-deficient mutants. Immunohistochemistry showed that the staining for GD1 alpha in rat and mouse cerebella was mostly found in the proximal dendrites and cell bodies of Purkinje cells. Also, it appeared slightly in the processes of Bergmann glial cells. The immunoreactivity of GD1 alpha disappeared specifically from the Purkinje cell dendrites and the Bergmann glial processes after co-application of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and 8-bromo-guanosine 3':5'-cyclic monophosphate, which induced long-term desensitization of the AMPA-selective glutamate receptors in Purkinje cells. The present data provide suggestive evidence that GD1 alpha ganglioside is enriched in Purkinje cells and may have a role in Purkinje cell functions in the cerebellum.
α-系列神经节苷脂IV3NeuAc,III6NeuAcGgOse4-Cer(GD1α),先前被鉴定为牛脑神经节苷脂中的一种次要成分(平林洋、兵库安、中尾彻、土屋健、铃木洋、松本真、近藤健和安藤幸,(1990年)《生物化学杂志》265卷,8144 - 8151页)。在本研究中,我们制备了一种针对GD1α的特异性小鼠单克隆抗体,并探究了GD1α在小鼠中枢神经系统中的分布。在成年大鼠脑中,GD1α作为一种次要成分存在,其表达仅在前脑、中脑和小脑中被检测到。在小鼠小脑中,GD1α的含量在浦肯野细胞缺陷型突变体摇椅小鼠(Lc/+)、蹒跚小鼠(sg/sg)和浦肯野细胞变性小鼠(pcd/pcd)中显著降低,但在主要失去颗粒细胞的织工小鼠(wv/wv)突变体中未降低。在小脑微粒体中检测的GD1α合酶在浦肯野细胞缺陷型突变体中也减少。免疫组织化学显示,大鼠和小鼠小脑对GD1α的染色主要出现在浦肯野细胞的近端树突和细胞体中。此外,在伯格曼胶质细胞的突起中也有轻微出现。在共同应用α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)和8-溴鸟苷3':5'-环一磷酸后,GD1α的免疫反应性从浦肯野细胞树突和伯格曼胶质细胞突起中特异性消失,这诱导了浦肯野细胞中AMPA选择性谷氨酸受体的长期脱敏。目前的数据提供了提示性证据,表明GD1α神经节苷脂在浦肯野细胞中富集,并且可能在小脑浦肯野细胞功能中发挥作用。